Scholarlink

<p>High-intensity focused ultrasound (HIFU) is a novel non-invasive technique with tremendous potential applications. However, ensuring effectiveness and safety of HIFU therapy remains a substantial challenge. Changing the acoustic environment of tumor tissues is an emerging way to solve this problem. In this study, we successfully constructed a bacteria-based nanocomposite, consisting genetically engineered bacteria (GVs-<i>E.coli</i>) and perfluorohexane/poly(lactic-co-glycolic acid) (PFH/PLGA) nanoparticles, which is denoted as GVs-E@PP NPs. We demonstrated that GVs-E@PP NPs could selectively target and proliferate in the tumor sites, and enhance the efficacy of HIFU therapy by changing the acoustic environment of tumor tissues. Specifically, they induced an increase in collagen fibers, elastic modulus, sound velocity and sound attenuation within tumor tissues, while simultaneously reducing tumor angiogenesis. These comprehensive changes facilitated the therapeutic efficacy of HIFU treatment. In summary, this approach represents an innovative therapeutic strategy to enhance HIFU synergy in tumor treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetically engineered bacteria-based nanocomposite synergistic HIFU for tumor therapy by changing the acoustic environment of tumor tissues

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月4日

查看全文
  • Ting Gong,
  • Wen Zhao,
  • Youqiang Chen,
  • Youqian He,
  • Jie Xiong,
  • Yijun Xiong,
  • Liu Yin,
  • Yong Luo,
  • Yi Tang

摘要

High-intensity focused ultrasound (HIFU) is a novel non-invasive technique with tremendous potential applications. However, ensuring effectiveness and safety of HIFU therapy remains a substantial challenge. Changing the acoustic environment of tumor tissues is an emerging way to solve this problem. In this study, we successfully constructed a bacteria-based nanocomposite, consisting genetically engineered bacteria (GVs-E.coli) and perfluorohexane/poly(lactic-co-glycolic acid) (PFH/PLGA) nanoparticles, which is denoted as GVs-E@PP NPs. We demonstrated that GVs-E@PP NPs could selectively target and proliferate in the tumor sites, and enhance the efficacy of HIFU therapy by changing the acoustic environment of tumor tissues. Specifically, they induced an increase in collagen fibers, elastic modulus, sound velocity and sound attenuation within tumor tissues, while simultaneously reducing tumor angiogenesis. These comprehensive changes facilitated the therapeutic efficacy of HIFU treatment. In summary, this approach represents an innovative therapeutic strategy to enhance HIFU synergy in tumor treatment.